Finance

Lists
036480:KOSDAQ
Daesung Microbiological Labs, Co., Ltd.
â‚©6,470.00
-0.61%
(-40.00) 1D
Jul 24, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 036480...
Open
â‚©6,510
High
â‚©6,510
Low
â‚©6,410
Mkt. cap
24.59B
Avg. vol.
13.78K
Volume
2.69K
Dividend
1.16%
Quarterly dividend
â‚©19
Ex-dividend date
Dec 27, 2024
P/E ratio
37.61
52-wk high
â‚©10,960
52-wk low
â‚©5,400
EPS
â‚©172
Shares outstanding
3.80M
No. of employees
141
Open
â‚©6,510
High
â‚©6,510
Low
â‚©6,410
Mkt. cap
24.59B
Avg. vol.
13.78K
Volume
2.69K
Dividend
1.16%
Quarterly dividend
â‚©19
Ex-dividend date
Dec 27, 2024
P/E ratio
37.61
52-wk high
â‚©10,960
52-wk low
â‚©5,400
EPS
â‚©172
Shares outstanding
3.80M
No. of employees
141
News stories
From sources across the web
About Daesung Microbiological Labs, Co., Ltd.
CEO-
Employees141
Founded1966
Headquarters-
SectorBiotechnology
Websitedsmbio.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.69B
7.18B
6.92B
5.08B
Cost of goods sold
4.64B
5.28B
5.52B
4.12B
Cost of revenue
4.64B
5.28B
5.52B
4.12B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.32B
1.31B
1.44B
1.19B
Operating expense
1.32B
1.31B
1.67B
1.47B
Total operating expenses
5.96B
6.59B
7.19B
5.60B
Operating income
727.65M
590.74M
-269.69M
-515.79M
Other non operating income
-512.20M
103.75M
33.43M
6.39M
EBT including unusual items
215.44M
694.49M
-253.44M
-258.74M
EBT excluding unusual items
215.44M
694.49M
-253.42M
-260.67M
Income tax expense
349.13M
-58.14M
-496.63M
-50.33M
Effective tax rate
162.05%
-8.37%
195.95%
19.45%
Other operating expenses
-
-
21.01M
22.64M
Net income
-133.69M
752.64M
243.19M
-208.41M
Net profit margin
-2.00%
10.48%
3.52%
-4.10%
Earnings per share
-
-
-
-
Interest and investment income
-
-
58.77M
60.84M
Interest expense
-
-
-148.63M
-145.55M
Net interest expenses
-
-
-89.86M
-84.71M
Depreciation and amortization charges
-
-
82.03M
79.95M
EBITDA
1.37B
1.22B
363.04M
113.18M
Gain or loss from assets sale
-2.73M
-
-
-1.95M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer